The Thrombosis Research Institute will be presenting data from the GARFIELD-AF registry at the joint meeting of the 10th APHRS and the 64th JHRS which takes place in Yokohama, Japan from 14 to 17 September, 2017.
This will commence with a Teatime Seminar on Thursday 14 September, entitled “Clinical and economic burden of atrial fibrillation (AF) in Asia: real-life data from the GARFIELD-AF registry”, and co-chaired by Professors Shinya Goto and John Camm. The data will be presented by a panel of international speakers from Japan, India, Korea and Singapore, and will cover the following topics:
Professor Zhi-Cheng Jing, MD, PhD, Professor of Cardiology, FuWai Hospital & State Key Lab of Cardiovascular Disease, Pekin Union will deliver his oral presentation, “Baseline characteristics and treatment patterns in patients with newly diagnosed atrial fibrillation (AF) in Asian countries: Insights from GARFIELD-AF”, also on the first day of Congress highlighting the variations of patient profiles and antithrombotic therapies among Asian countries.
In the same session, Dr Kengo Ayabe, Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan will deliver his oral presentation, “Risk factor profile and management of patients with diabetes mellitus (DM) and newly diagnosed atrial fibrillation in Asia: results from GARFIELD-AF”. Dr Ayabe’s presentation will highlight the variations in risk profile and anticoagulant use in Asian and non-Asian patients with and without DM, as shown in the global real-world dataset.
On the following day Dr Shinichi Goto, also from Tokai University School of Medicine will deliver his oral presentation, “Risk factor profile and management of patients with chronic kidney disease (CKD) and newly diagnosed atrial fibrillation in Asia: Results from GARFIELD-AF”, focusing on the real-world differences in risk profile and treatment patterns that were observed in Asian and non-Asian AF and CKD patients.
Speaking last month at the ESC Congress 2017 about the global data, Professor Goto commented: “Surprisingly, the use of oral anticoagulants in patients with AF was similar across the stages of CKD even though patients with moderate-to-severe CKD demonstrated a higher risk of stroke/SE, serious bleeding and mortality than those with no CKD. Similar trends were shown in most regions for the three endpoints.”
Location: PACIFICO Yokohama Conference Center (Exhibition Hall C), InterContinental Yokohama Grand, 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan
Dates: Thursday 14 September 2017 – Sunday 17 September 2017
Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates